Literature DB >> 3491793

Purified colony stimulating factors (G-CSF and GM-CSF) induce differentiation in human HL60 leukemic cells with suppression of clonogenicity.

C G Begley, D Metcalf, N A Nicola.   

Abstract

Purified recombinant human granulocyte-macrophage colony-stimulating factor (rHGM-CSF) and purified native murine granulocyte-CSF (G-CSF) both induced differentiation in HL60 cells as evidenced by expression of granulocyte and macrophage membrane antigens, although this was not accompanied by morphological evidence of differentiation. Both types of CSF suppressed clonogenic HL60 cells with evidence of complete clonal extinction. The suppression of clonogenic HL60 cells was preceded in some experiments by CSF-stimulated proliferation of HL60 cells, and this was most evident in cultures containing low concentrations of fetal calf serum (FCS).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3491793     DOI: 10.1002/ijc.2910390118

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

Review 1.  G-CSF: status quo and new indications.

Authors:  F Herrmann
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

Review 2.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines.

Authors:  A Smith; D Metcalf; N A Nicola
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

Review 4.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

5.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

6.  Gene technology and the drugs of tomorrow.

Authors:  J Drews
Journal:  Pharm Weekbl Sci       Date:  1990-02-23

7.  Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript.

Authors:  C G Begley; P D Aplan; M P Davey; K Nakahara; K Tchorz; J Kurtzberg; M S Hershfield; B F Haynes; D I Cohen; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

Review 8.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

9.  Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines.

Authors:  K E Cha; S Y Yoon; K N Lee
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

10.  Synergistic suppression: anomalous inhibition of the proliferation of factor-dependent hemopoietic cells by combination of two colony-stimulating factors.

Authors:  D Metcalf; N A Nicola; N M Gough; M Elliott; G McArthur; M Li
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.